__timestamp | Bausch Health Companies Inc. | Bio-Techne Corporation |
---|---|---|
Wednesday, January 1, 2014 | 6008900000 | 251411000 |
Thursday, January 1, 2015 | 7853800000 | 307277000 |
Friday, January 1, 2016 | 7063000000 | 336659000 |
Sunday, January 1, 2017 | 6176000000 | 374541000 |
Monday, January 1, 2018 | 6029000000 | 432143000 |
Tuesday, January 1, 2019 | 6251000000 | 473491000 |
Wednesday, January 1, 2020 | 5778000000 | 483194000 |
Friday, January 1, 2021 | 6040000000 | 632850000 |
Saturday, January 1, 2022 | 5760000000 | 756496000 |
Sunday, January 1, 2023 | 6198000000 | 769815000 |
Monday, January 1, 2024 | 769725000 |
Unlocking the unknown
In the ever-evolving landscape of the biotech and healthcare industries, understanding financial trends is crucial. This analysis focuses on the gross profit trajectories of Bio-Techne Corporation and Bausch Health Companies Inc. from 2014 to 2023.
Bio-Techne has shown a remarkable upward trend, with gross profits increasing by over 200% from 2014 to 2023. This growth highlights the company's strategic advancements and robust market positioning, especially in the latter half of the decade.
Conversely, Bausch Health's gross profit has experienced fluctuations, peaking in 2015 and then stabilizing around a 10% lower average in subsequent years. This pattern reflects the challenges faced in the competitive healthcare market.
Overall, while Bio-Techne's consistent growth underscores its innovative edge, Bausch Health's performance suggests a need for strategic recalibration to regain its former financial heights.
Gross Profit Comparison: Merck & Co., Inc. and Bausch Health Companies Inc. Trends
Gross Profit Comparison: Novartis AG and Bio-Techne Corporation Trends
Key Insights on Gross Profit: Novartis AG vs Bausch Health Companies Inc.
Zoetis Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Incyte Corporation and Bio-Techne Corporation Trends
Incyte Corporation vs Bausch Health Companies Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Viatris Inc. vs Bio-Techne Corporation
Gross Profit Comparison: Bio-Techne Corporation and Exelixis, Inc. Trends
Research and Development Investment: Bio-Techne Corporation vs Bausch Health Companies Inc.
Exelixis, Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bausch Health Companies Inc. vs Taro Pharmaceutical Industries Ltd.
Bausch Health Companies Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown